Pancreatic Cancer Research

ResearcherUniversity of California, Los AngelesNo recent work listed

Hanlin L. Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-1409-5234; OpenAlex author ID A5019364542. Sources: OpenAlex.

Their work

Papers
4 (first author 0, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
11
Papers, trials and grants by year

2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: none · 2019: 2 papers · 2020: none · 2021: 1 paper

Papers 4

  1. Poorly differentiated histologic grade correlates with worse survival in SMAD4 negative pancreatic adenocarcinoma patients. Co-author DOI 10.1002/jso.26279↗
  2. Comparative Accuracy of Tumor Size Assessment and Stage Analysis by Imaging Modalities Versus Gross Examination for Pancreatic Ductal Adenocarcinoma. Last author DOI 10.1097/mpa.0000000000001233↗
  3. Impact of Changes in the American Joint Committee on Cancer Staging Manual, Eighth Edition, for Pancreatic Ductal Adenocarcinoma. Last author DOI 10.1097/mpa.0000000000001349↗
  4. Immunohistochemical distinction between intrahepatic cholangiocarcinoma and pancreatic ductal adenocarcinoma. Last author DOI 10.1016/j.humpath.2013.10.004↗

Closest collaborators

The 11 strongest of 11 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ari Kassardjian · 2 shared papers, 2019 · strength 0.27
  2. Timothy R. Donahue · 2 shared papers, 2019–2021 · strength 0.24
  3. Zev A. Wainberg · 2 shared papers, 2019–2021 · strength 0.24
  4. Howard A. Reber · 1 shared paper, 2021 · strength 0.13
  5. Michael A. Mederos · 1 shared paper, 2021 · strength 0.13
  6. Joon Y. Park · 1 shared paper, 2021 · strength 0.13
  7. Mark D. Girgis MD · 1 shared paper, 2021 · strength 0.13
  8. Jonathan C. King · 1 shared paper, 2021 · strength 0.13
  9. Oscar Joe Hines · 1 shared paper, 2021 · strength 0.13
  10. David W. Dawson · 1 shared paper, 2021 · strength 0.13
  11. Terry Lok · 1 shared paper, 2014 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.